Dr. Lydia Shajenko M.D.

Additional Information

Lydia Shajenko, MD, PhD, is a Top Neurologist and Clinical Neurophysiologist Seeing Patients at Her Own Private Practice in Edgewater, NJ

Lydia Shajenko, MD, PhD, is a top neurologist and clinical neurophysiologist who lends his skills and expertise to serve patients at her private practice, the Brain Institute of Northern New Jersey, in Edgewater, NJ. She can also be found on staff at Hackensack Meridian Palisades General Hospital in North Bergen, NJ, and Holy Name Hospital in Teaneck, NJ. With twenty years of experience as a neurologist and nineteen years as a clinical neurophysiologist, Dr. Shajenko specializes in treating diseases of the nervous system, which includes the brain and spinal cord. She is recognized as an expert in the treatment of a full range of neurological disorders, including headaches, migraines, neck pain, back pain, seizure disorders, epilepsy, carpal tunnel syndrome, neuropathy, etc. At her office, Dr. Shajenko performs cutting edge procedures such as electromyography, electroencephalogram, Vagus Nerve Stimulation, and videonystagmography. For more information about Lydia Shajenko, MD, PhD, please visit https://lydiashajenkomd.com/index.html.

Lydia Shajenko, MD, PhD, is a 1997-graduate of the University of Connecticut School of Medicine in Farmington, CT. His postgraduate training includes her internship conducted at the Medical College of Virginia in Richmond, VA (1997-1998), and neurology residency served at Mount Sinai Hospital in New York, NY (1998-2001). Dr. Shajenko further completed a clinical neurophysiology fellowship at NYU Grossman School of Medicine (2001-2002). She attained board certification in neurology and the subspecialty of clinical neurophysiology with the American Board of Psychiatry and Neurology. Furthermore, she holds experience in studying the neurotoxic mechanisms of amyloid beta-peptide in Alzheimer’s Disease. For more information about Dr. Lydia Shajenko, please visit https://www.findatopdoc.com/doctor/1902402-Lydia-Shajenko-Neurologist.

Recommended Articles

• Treatment for Meningitis

  The severity of meningitis varies from one person to another. In common cases, medications can help solve the problem and the person may recover within 1 to 3 weeks. But in cases where there is a risk of the infection spreading to the meninges, hospitalization and other confirmation tests might be...

• Is Restless Legs Syndrome Chronic?

  Restless legs syndrome is not chronic. RLS is a neurological movement disorder of the limbs. It is usually associated with sleep disruptions. Patients with RLS will usually report strange sensations, such as an urge to move their leg. This can become very bothersome, which can lead to physical as...

• An Open Letter to Multiple Sclerosis Spouses

  Marriage holds so much promise. Multiple sclerosis can shake the foundation to its core. When this happens, sometimes the vows once taken get lost in all of the medical and physical needs of the patient. This is a message for those spouses of MS patients who may give in to the frustration and...

• What is Epilepsy?

  Epilepsy is a neurological disorder with abnormal electrical activity in the brain, which results in repeated seizures or fits. It is a very common condition and affects millions of people in the country. Although the condition may start at any age, it is usually found to start in childhood, in most...

• What Is the Difference Between Depression and Anxiety?

  Understanding the difference between depression and anxiety is not an easy task, as mental health conditions are far more complicated. The most common mental illnesses are depression, anxiety, and substance use disorder. It is common for these three types of mental illnesses to occur in combination....

• Dogs Show Improvement After Gene Therapy for Muscular Dystrophy

  Duchenne muscular dystrophy is a progressive disease that causes body muscle weakness and atrophy as a result of a deficiency in dystrophin protein. A scientist at the University of Washington, the University of Missouri, LLC, Solid Biosciences, and NCATS have developed a gene transfer approach to...